The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Brighton Pier profit surges on strong summer

Mon, 28th Mar 2022 10:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cambridge Cognition Holdings PLC, up 13% at 136.94 pence, 12-month range 82.00p-195.00p. The Cambridge-based neuroscience technology company wins a "pivotal" GBP1 million pact concerning an autoimmune trial. Cambridge Cognition has been picked by a "top 10 pharmaceutical company" to provide digital cognitive assessments for the phase III probe. "Revenue from the contract is expected over the next three years," the AIM listing says.

----------

Brighton Pier Group PLC, up 9.8% at 92.22 pence, 12-month range 34.00p-97.20p. The company, which operates Brighton Marine Palace as well as bars and indoor mini-golf sites, says annual earnings jump. Revenue in the financial year that ended December 26 rise sharply to GBP22.8 million from GBP8.2 million. Pretax profit multiplies to GBP6.6 million from GBP2.7 million. Brighton Pier attributes its stronger top and bottom line figures a "record summer trading period". Shares hit this one-year high on Monday.

----------

AIM - LOSERS

----------

Summerway Capital PLC down 8.9% at 144.00p, 12-month range 90.00p-278.50p. Shares fall following completion of acquisition of Vertigrow Technology Ltd, or Celadon Pharmaceuticals. Name change to Celadon Pharmaceuticals PLC will take effect on Tuesday. Celadon is acquired by way of reverse takeover worth GBP80 million. Summerway funds the deal through an issue of 48.5 million shares at 165 pence each. Summerway, which prior to acquisition invested in household and consumer goods sectors, is now a cannabinoid-based-medicine-focused pharmaceutical company.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
27 Mar 2022 10:38

Sunday share tips: Cambridge Cognition Holdings, FRP

(Sharecast News) - The Sunday Times's Lucy Tobin tipped shares of neuroscience outfit Cambridge Cognition Holdings to readers.

Read more
2 Feb 2022 12:40

Cambridge Cognition awarded contracts worth £2.1m

(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts worth £2.1m, it announced on Wednesday, to provide cognitive assessments, electronic diaries, and third-party hardware for two clinical trials in neurodegenerative disease.

Read more
2 Feb 2022 10:45

Cambridge Cognition jumps on GBP2.1 million clinical trial contract

Cambridge Cognition jumps on GBP2.1 million clinical trial contract

Read more
2 Feb 2022 10:32

AIM WINNERS & LOSERS: AFC gets Extreme E boost; Chamberlin raises cash

AIM WINNERS & LOSERS: AFC gets Extreme E boost; Chamberlin raises cash

Read more
27 Jan 2022 17:49

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust

Read more
10 Jan 2022 12:44

Cambridge Cognition wins contracts for two clinical trials

(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts for two clinical trials by an unnamed "top 20" pharmaceutical company, it announced on Monday, to assess the pro-cognitive effects of a new drug in schizophrenia.

Read more
10 Jan 2022 12:19

Cambridge Cognition wins assessment contracts for schizophrenia drug

Cambridge Cognition wins assessment contracts for schizophrenia drug

Read more
16 Dec 2021 21:55

IN BRIEF: Cambridge Cognition wins second GBP500,000 contract

IN BRIEF: Cambridge Cognition wins second GBP500,000 contract

Read more
10 Dec 2021 15:03

TRADING UPDATES: Omega disputes repayment; BWA applies for licenses

TRADING UPDATES: Omega disputes repayment; BWA applies for licenses

Read more
2 Nov 2021 15:01

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

Read more
26 Oct 2021 17:39

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

Read more
26 Oct 2021 09:11

Cambridge Cognition secures contract for 'sizeable' schizophrenia trial

(Sharecast News) - Digital brain health technology company Cambridge Cognition has secured a contract for a further sizeable schizophrenia trial with an existing customer, it announced on Tuesday.

Read more
21 Sep 2021 11:54

TRADING UPDATES: Cambridge Cognition in profit; PensionBee loss widens

TRADING UPDATES: Cambridge Cognition in profit; PensionBee loss widens

Read more
14 Sep 2021 16:11

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
3 Aug 2021 12:03

TRADING UPDATES: UK housing market boosts Belvoir; IOG spuds Blythe

TRADING UPDATES: UK housing market boosts Belvoir; IOG spuds Blythe

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.